文献速递免疫规划卫生政策与健康促进

冠状病毒疫苗库的启动

Initiation of a coronavirus vaccine library.
PubMed 文献 · Vaccine · 2025-12-20

冠状病毒持续从动物宿主溢出威胁全球健康,流行病防范创新联盟(CEPI)启动冠状病毒疫苗库计划,基于专家咨询和已发表数据制定26种冠状病毒优先清单,将用计算机设计稳定刺突抗原并进行临床前免疫原性和广度测试,生成开放获取库以加速新发冠状病毒疫苗研发。

要点

  • CEPI启动冠状病毒疫苗库计划,优先评估溢出风险、疫苗可行性和系统发育覆盖。
  • 基于专家咨询和已发表数据制定26种冠状病毒优先清单。
  • 将用计算机设计稳定刺突抗原,进行临床前免疫原性和广度测试。

核心结论

  • CEPI的冠状病毒疫苗库计划旨在生成知识和工具,以加速针对新发冠状病毒的疫苗开发。

研究设计与样本

  • 基于专家咨询和已发表数据,制定26种冠状病毒优先清单,作为构建知识库的基础。

主要发现

  • 优先清单包含26种冠状病毒,优先考虑评估溢出风险最高、疫苗可行性和系统发育覆盖的病毒。

关键数值与推荐

  • 作为第一步,将使用计算机设计为选定靶点开发稳定刺突抗原。
  • 这些抗原将使用不同疫苗模态进行临床前免疫原性和广度测试。
  • 生成的检测方法、工具和数据将汇聚成开放获取库。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Coronaviruses (CoVs) continue to pose a global health threat as they spill over from animal hosts to humans. The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership focused on vaccine research and development. CEPI's CoV Vaccine Library initiative aims to generate knowledge and tools to accelerate vaccine development against emergent CoVs, prioritizing those with the highest assessed risk of spillover, vaccine feasibility, and phylogenetic coverage. Based on expert consultations and published data, we developed a prioritized list of 26 CoVs to serve as a foundation for building a knowledge base to support future vaccine efforts. As a first step, in silico designs will be used to develop stabilized spike antigens for select targets. These antigens will be tested for pre-clinical immunogenicity and breadth using different vaccine modalities. Assays, tools, and data generated will nucleate an open-access library and serve as a starting point for emergent CoV vaccine development.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kovacs D, Brar G, Anthony SJ, et al. Initiation of a coronavirus vaccine library. Vaccine. 2025. PMID: 41422789. doi:10.1016/j.vaccine.2025.128140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。